APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hemophilia AAV Gene Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hemophilia AAV Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025175 pages

Choose your research edition.

Industry ResearchHemophilia AAV Gene Therapy Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Hemophilia AAV Gene Therapy Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Hemophilia AAV Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hemophilia AAV Gene Therapy Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Hemophilia AAV Gene Therapy Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Hemophilia AAV Gene Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Hemophilia AAV Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hemophilia AAV Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hemophilia AAV Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hemophilia AAV Gene Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hemophilia AAV Gene Therapy include Pfizer, CSL/uniQure (Hemgenix&Glybera) and BioMarin (Roctavian), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Hemophilia AAV Gene Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hemophilia AAV Gene Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hemophilia AAV Gene Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Hemophilia AAV Gene Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Hemophilia AAV Gene Therapy Segment by Company

Pfizer

CSL/uniQure (Hemgenix&Glybera)

BioMarin (Roctavian)

Hemophilia AAV Gene Therapy Segment by Type

AVV5 Vector

AAVrh74 Vector

Hemophilia AAV Gene Therapy Segment by Application

Hemophilia A

Hemophilia B

Hemophilia AAV Gene Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hemophilia AAV Gene Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hemophilia AAV Gene Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hemophilia AAV Gene Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Hemophilia AAV Gene Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Hemophilia AAV Gene Therapy industry.

Chapter 3: Detailed analysis of Hemophilia AAV Gene Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemophilia AAV Gene Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Hemophilia AAV Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of AVV5 Vector Table 3. Key Players of AAVrh74 Vector Table 4. Global Hemophilia AAV Gene Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hemophilia A Table 6. Key Players of Hemophilia B Table 7. Global Hemophilia AAV Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Hemophilia AAV Gene Therapy Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Hemophilia AAV Gene Therapy Market Share by Region (2021-2026) Table 10. Global Hemophilia AAV Gene Therapy Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Hemophilia AAV Gene Therapy Market Share by Region (2027-2032) Table 12. Hemophilia AAV Gene Therapy Industry Trends Table 13. Hemophilia AAV Gene Therapy Industry Drivers Table 14. Hemophilia AAV Gene Therapy Industry Opportunities and Challenges Table 15. Hemophilia AAV Gene Therapy Industry Restraints Table 16. Global Hemophilia AAV Gene Therapy Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Hemophilia AAV Gene Therapy Revenue Market Share by Company (2021-2026) Table 18. Global Hemophilia AAV Gene Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Hemophilia AAV Gene Therapy Key Company Head Office and Area Served Table 20. Global Hemophilia AAV Gene Therapy Company, Product Type & Application Table 21. Global Hemophilia AAV Gene Therapy Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Hemophilia AAV Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Hemophilia AAV Gene Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Hemophilia AAV Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Hemophilia AAV Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Hemophilia AAV Gene Therapy Revenue Market Share by Type (2021-2026) Table 28. Global Hemophilia AAV Gene Therapy Revenue Market Share by Type (2027-2032) Table 29. Global Hemophilia AAV Gene Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Hemophilia AAV Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Hemophilia AAV Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Hemophilia AAV Gene Therapy Revenue Market Share by Application (2021-2026) Table 33. Global Hemophilia AAV Gene Therapy Revenue Market Share by Application (2027-2032) Table 34. Pfizer Company Information Table 35. Pfizer Business Overview Table 36. Pfizer Hemophilia AAV Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Pfizer Hemophilia AAV Gene Therapy Product Portfolio Table 38. Pfizer Recent Development Table 39. CSL/uniQure (Hemgenix&Glybera) Company Information Table 40. CSL/uniQure (Hemgenix&Glybera) Business Overview Table 41. CSL/uniQure (Hemgenix&Glybera) Hemophilia AAV Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. CSL/uniQure (Hemgenix&Glybera) Hemophilia AAV Gene Therapy Product Portfolio Table 43. CSL/uniQure (Hemgenix&Glybera) Recent Development Table 44. BioMarin (Roctavian) Company Information Table 45. BioMarin (Roctavian) Business Overview Table 46. BioMarin (Roctavian) Hemophilia AAV Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. BioMarin (Roctavian) Hemophilia AAV Gene Therapy Product Portfolio Table 48. BioMarin (Roctavian) Recent Development Table 49. North America Hemophilia AAV Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 50. North America Hemophilia AAV Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 51. North America Hemophilia AAV Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 52. North America Hemophilia AAV Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 53. North America Hemophilia AAV Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 54. North America Hemophilia AAV Gene Therapy Market Size by Country (2021-2026) Table 55. North America Hemophilia AAV Gene Therapy Market Size by Country (2027-2032) Table 56. Europe Hemophilia AAV Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 57. Europe Hemophilia AAV Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 58. Europe Hemophilia AAV Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 59. Europe Hemophilia AAV Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 60. Europe Hemophilia AAV Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 61. Europe Hemophilia AAV Gene Therapy Market Size by Country (2021-2026) Table 62. Europe Hemophilia AAV Gene Therapy Market Size by Country (2027-2032) Table 63. China Hemophilia AAV Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 64. China Hemophilia AAV Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 65. China Hemophilia AAV Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 66. China Hemophilia AAV Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 67. Asia Hemophilia AAV Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 68. Asia Hemophilia AAV Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 69. Asia Hemophilia AAV Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 70. Asia Hemophilia AAV Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 71. Asia Hemophilia AAV Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Asia Hemophilia AAV Gene Therapy Market Size by Country (2021-2026) Table 73. Asia Hemophilia AAV Gene Therapy Market Size by Country (2027-2032) Table 74. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Type (2021-2026) & (US$ Million) Table 75. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Type (2027-2032) & (US$ Million) Table 76. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Application (2021-2026) & (US$ Million) Table 77. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Application (2027-2032) & (US$ Million) Table 78. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 79. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (2021-2026) Table 80. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (2027-2032) Table 81. Research Programs/Design for This Report Table 82. Authors List of This Report Table 83. Secondary Sources Table 84. Primary Sources List of Figures Figure 1. Hemophilia AAV Gene Therapy Product Image Figure 2. Global Hemophilia AAV Gene Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Hemophilia AAV Gene Therapy Market Share by Type: 2025 VS 2032 Figure 4. AVV5 Vector Image Figure 5. AAVrh74 Vector Image Figure 6. Global Hemophilia AAV Gene Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Hemophilia AAV Gene Therapy Market Share by Application: 2025 VS 2032 Figure 8. Hemophilia A Image Figure 9. Hemophilia B Image Figure 10. Global Hemophilia AAV Gene Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 12. Global Hemophilia AAV Gene Therapy Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Hemophilia AAV Gene Therapy Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Hemophilia AAV Gene Therapy Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Hemophilia AAV Gene Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Hemophilia AAV Gene Therapy Revenue Market Share by Type (2021-2032) Figure 19. Global Hemophilia AAV Gene Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Hemophilia AAV Gene Therapy Revenue Market Share by Application (2021-2032) Figure 21. North America Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 22. North America Hemophilia AAV Gene Therapy Market Share by Type (2021-2032) Figure 23. North America Hemophilia AAV Gene Therapy Market Share by Application (2021-2032) Figure 24. North America Hemophilia AAV Gene Therapy Market Share by Country (2021-2032) Figure 25. United States Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 26. Canada Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Europe Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Europe Hemophilia AAV Gene Therapy Market Share by Type (2021-2032) Figure 30. Europe Hemophilia AAV Gene Therapy Market Share by Application (2021-2032) Figure 31. Europe Hemophilia AAV Gene Therapy Market Share by Country (2021-2032) Figure 32. Germany Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 33. France Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 35. Italy Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 36. Russia Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 38. China Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 39. China Hemophilia AAV Gene Therapy Market Share by Type (2021-2032) Figure 40. China Hemophilia AAV Gene Therapy Market Share by Application (2021-2032) Figure 41. Asia Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 42. Asia Hemophilia AAV Gene Therapy Market Share by Type (2021-2032) Figure 43. Asia Hemophilia AAV Gene Therapy Market Share by Application (2021-2032) Figure 44. Asia Hemophilia AAV Gene Therapy Market Share by Country (2021-2032) Figure 45. Japan Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 49. India Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 50. Australia Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Share by Country (2021-2032) Figure 55. Brazil Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 60. UAE Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Chile Hemophilia AAV Gene Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • AVV5 Vector
  • AAVrh74 Vector
Applications
  • Hemophilia A
  • Hemophilia B
Companies covered
  • Pfizer
  • CSL/uniQure (Hemgenix&Glybera)
  • BioMarin (Roctavian)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Hemophilia AAV Gene Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 AVV5 Vector
  5. 1.2.3 AAVrh74 Vector
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Hemophilia AAV Gene Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Hemophilia A
  9. 1.3.3 Hemophilia B
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Hemophilia AAV Gene Therapy Growth Trends by Region
  12. 1.5.1 Global Hemophilia AAV Gene Therapy Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Hemophilia AAV Gene Therapy Market Size by Region (2021-2026)
  14. 1.5.3 Hemophilia AAV Gene Therapy Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Hemophilia AAV Gene Therapy Market Dynamics
  1. 2.1 Hemophilia AAV Gene Therapy Industry Trends
  2. 2.2 Hemophilia AAV Gene Therapy Industry Drivers
  3. 2.3 Hemophilia AAV Gene Therapy Industry Opportunities and Challenges
  4. 2.4 Hemophilia AAV Gene Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Hemophilia AAV Gene Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Hemophilia AAV Gene Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Hemophilia AAV Gene Therapy Key Company Head office and Area Served
  4. 3.4 Global Hemophilia AAV Gene Therapy Company, Product Type & Application
  5. 3.5 Global Hemophilia AAV Gene Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Hemophilia AAV Gene Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Hemophilia AAV Gene Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Hemophilia AAV Gene Therapy Tier 1, Tier 2, and Tier 3
4 Hemophilia AAV Gene Therapy Market by Type
  1. 4.1 Global Hemophilia AAV Gene Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Hemophilia AAV Gene Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Hemophilia AAV Gene Therapy Market Size Share by Type (2021-2032)
5 Hemophilia AAV Gene Therapy Market by Application
  1. 5.1 Global Hemophilia AAV Gene Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Hemophilia AAV Gene Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Hemophilia AAV Gene Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Pfizer
  2. 6.1.1 Pfizer Company Information
  3. 6.1.2 Pfizer Business Overview
  4. 6.1.3 Pfizer Hemophilia AAV Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Pfizer Hemophilia AAV Gene Therapy Product Portfolio
  6. 6.1.5 Pfizer Recent Developments
  7. 6.2 CSL/uniQure (Hemgenix&Glybera)
  8. 6.2.1 CSL/uniQure (Hemgenix&Glybera) Company Information
  9. 6.2.2 CSL/uniQure (Hemgenix&Glybera) Business Overview
  10. 6.2.3 CSL/uniQure (Hemgenix&Glybera) Hemophilia AAV Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 CSL/uniQure (Hemgenix&Glybera) Hemophilia AAV Gene Therapy Product Portfolio
  12. 6.2.5 CSL/uniQure (Hemgenix&Glybera) Recent Developments
  13. 6.3 BioMarin (Roctavian)
  14. 6.3.1 BioMarin (Roctavian) Company Information
  15. 6.3.2 BioMarin (Roctavian) Business Overview
  16. 6.3.3 BioMarin (Roctavian) Hemophilia AAV Gene Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 BioMarin (Roctavian) Hemophilia AAV Gene Therapy Product Portfolio
  18. 6.3.5 BioMarin (Roctavian) Recent Developments
7 North America
  1. 7.1 North America Hemophilia AAV Gene Therapy Market Size (2021-2032)
  2. 7.2 North America Hemophilia AAV Gene Therapy Market Size by Type
  3. 7.2.1 North America Hemophilia AAV Gene Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Hemophilia AAV Gene Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Hemophilia AAV Gene Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Hemophilia AAV Gene Therapy Market Size by Application
  7. 7.3.1 North America Hemophilia AAV Gene Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Hemophilia AAV Gene Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Hemophilia AAV Gene Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Hemophilia AAV Gene Therapy Market Size by Country
  11. 7.4.1 North America Hemophilia AAV Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Hemophilia AAV Gene Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Hemophilia AAV Gene Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Hemophilia AAV Gene Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Hemophilia AAV Gene Therapy Market Size (2021-2032)
  2. 8.2 Europe Hemophilia AAV Gene Therapy Market Size by Type
  3. 8.2.1 Europe Hemophilia AAV Gene Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Hemophilia AAV Gene Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Hemophilia AAV Gene Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Hemophilia AAV Gene Therapy Market Size by Application
  7. 8.3.1 Europe Hemophilia AAV Gene Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Hemophilia AAV Gene Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Hemophilia AAV Gene Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Hemophilia AAV Gene Therapy Market Size by Country
  11. 8.4.1 Europe Hemophilia AAV Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Hemophilia AAV Gene Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Hemophilia AAV Gene Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Hemophilia AAV Gene Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Hemophilia AAV Gene Therapy Market Size (2021-2032)
  2. 9.2 China Hemophilia AAV Gene Therapy Market Size by Type
  3. 9.2.1 China Hemophilia AAV Gene Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Hemophilia AAV Gene Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Hemophilia AAV Gene Therapy Market Share by Type (2021-2032)
  6. 9.3 China Hemophilia AAV Gene Therapy Market Size by Application
  7. 9.3.1 China Hemophilia AAV Gene Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Hemophilia AAV Gene Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Hemophilia AAV Gene Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Hemophilia AAV Gene Therapy Market Size (2021-2032)
  2. 10.2 Asia Hemophilia AAV Gene Therapy Market Size by Type
  3. 10.2.1 Asia Hemophilia AAV Gene Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Hemophilia AAV Gene Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Hemophilia AAV Gene Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Hemophilia AAV Gene Therapy Market Size by Application
  7. 10.3.1 Asia Hemophilia AAV Gene Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Hemophilia AAV Gene Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Hemophilia AAV Gene Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Hemophilia AAV Gene Therapy Market Size by Country
  11. 10.4.1 Asia Hemophilia AAV Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Hemophilia AAV Gene Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Hemophilia AAV Gene Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Hemophilia AAV Gene Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Hemophilia AAV Gene Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst